register

News & Trends - MedTech & Diagnostics

28 million surgeries cancelled or postponed globally due to COVID-19 disruption

Health Industry Hub | May 20, 2020 |

MedTech News: Based on a 12-week period of peak disruption to hospital services due to COVID-19, 28.4 million elective surgeries worldwide will be cancelled or postponed in 2020.

The modelling study, published in the British Journal of Surgery, indicates that each additional week of disruption to hospital services will be associated with a further 2.4 million cancellations.

The researchers collected detailed information from surgeons across 359 hospitals and 71 countries on plans for the cancellation of elective surgery. This data was then statistically modelled to estimate totals for cancelled surgery across 190 countries. Royal Australasian College of Surgeons (RACS) Fellows and trainees have contributed significantly to the study.

The researchers project that worldwide 72.3% of planned operations will be cancelled through the peak period of COVID-19 related disruption. The majority of cancelled surgeries will be for non-cancer conditions; however, it is estimated that globally 2.3 million cancer surgeries will be cancelled or postponed. Orthopaedic procedures will be cancelled most frequently, with 6.3 million orthopaedic operations cancelled worldwide over a 12-week period.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

In Australia, so far there have been eight weeks of significant cancellations of most non-urgent elective surgery, from mid-March to mid-May. However, elective surgery is now restarting, with varying but often still significant restrictions on numbers of cases. In total, this period of restricted workload has created a backlog of almost 400,000 cases that will need to be cleared after the COVID-19 disruption ends.

Dr Philip Townend, Consultant Surgeon, Gold Coast University Hospital commented “During the COVID-19 pandemic elective surgeries have been cancelled to reduce the risk of patients being exposed to COVID-19 in hospital, and to support the wider hospital response, for example by converting operating theatres into intensive care units. Although essential, cancellations place a heavy burden on patients and society. Patients’ conditions may deteriorate, worsening their quality of life as they wait for rescheduled surgery. In some cases, for example cancer, delayed surgeries may lead to a number of unnecessary deaths.”

To give an impression of the scale of the backlog, if we had been able to go back to an enhanced service after the worst of the disruption ended in late April, with the hospital system increasing the number of surgeries performed each week by 20% compared to pre-pandemic activity, it would still have taken 22 weeks to clear the backlog.

In alignment with the Federal Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals. The initiative is supported by Medicines Australia, AusBiotech and ARCS Australia. Learn more.

Professor David Watson, Clinical Director of the RACS Clinical Trials Network Australia & New Zealand noted “This worldwide collaborative project to understand the consequences of COVID19 on surgery, including outcomes, service delivery and methods to reduce risk for patients and clinicians, has brought surgeons and their teams together to collect high quality data from across Australia and New Zealand. It is extending the work done in the past three years to establish collaborative research in surgery, involving all grades of surgeons from medical students to consultants, and in all the states, provinces and territories served by Fellows and trainees in our College.”

Dr Peter Pockney, Consultant Surgeon in Newcastle, NSW, and a member of the organising committee for the COVIDSurg project said “COVIDSurg is believed to be the biggest collaborative study ever conducted in Surgery. The contribution of RACS Trainees and Fellows, in Australia and NZ, has been vital in ensuring that the data produced and conclusions from it are valid and robust. The lessons learned will help health services plan, adapt and deliver high quality safe services as the pandemic progresses.”


News & Trends - MedTech & Diagnostics

Medtronic partners with local researchers in stroke trial

Medtronic partners with local researchers in stroke trial

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: Endovascular thrombectomy has been shown to be more effective in reducing disability than medical therapy alone […]

More


News & Trends - Pharmaceuticals

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Industry Hub | March 1, 2024 |

Pharma News: Mark Butler MP, Federal Minister for Health, and Senator Anne Ruston, Shadow Minister for Health, reflected on the […]

More


News & Trends - Pharmaceuticals

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Health Industry Hub | March 1, 2024 |

Pharma News: Gilead has applied to the Medical Services Advisory Committee (MSAC) for funding of its cutting-edge CAR T-cell therapy, […]

More


News & Trends - MedTech & Diagnostics

Should private insurers face scrutiny for soaring profits while patients foot the bill? MTAA, Private Healthcare Australia

Should private health insurers face scrutiny for soaring profits while patients foot the bill?

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: In a clash of interests, the Medical Technology Association of Australia (MTAA) has once again urged […]

More


This content is copyright protected. Please subscribe to gain access.